Member Posts > Cardiol Therapeutics to Highlight Cardiovascular Innovations at TD Cowen Conference
Cardiol Therapeutics Inc. has announced that it will showcase its latest advancements in cardiovascular medicine at the TD Cowen 45th Annual Health Care Conference in Boston on March 5, 2025, at 11:10 AM EST. The company will share updates on its ongoing research, clinical trials, and progress in developing novel anti-inflammatory and anti-fibrotic therapies.
With a strong reputation for leading-edge research, Cardiol Therapeutics has consistently presented at major industry events. The company recently participated in the Oppenheimer 35th Annual Healthcare Life Sciences Conference in February 2025, offering insights into its clinical pipeline and potential breakthroughs in cardiovascular health. Additionally, in September 2023, CEO David Elsley provided a strategic update at the Cantor Fitzgerald 2023 Global Healthcare Conference, highlighting the company's long-term vision.
Through these engagements, Cardiol Therapeutics reinforces its commitment to advancing cardiovascular treatments, addressing unmet medical needs, and improving patient care.

#CardiolTherapeutics #HeartDiseaseResearch #BiotechNews #PharmaInvestments #MedicalInnovation